Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infection Resistant to Drugs”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Testing effectiveness (Phase 2)Study completedNCT00727844
What this trial is testing

Linezolid to Treat Extensively-Drug Resistant Tuberculosis

Who this might be right for
Pulmonary TuberculosisMultidrug Resistant TuberculosisExtensively Drug Resistant Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 41
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Testing effectiveness (Phase 2)Looking for participantsNCT04648280
What this trial is testing

Safety and Pharmacokinetics Evaluation of Fostemsavir + (OBT) in HIV-1 Infected Children and Adolescents Who Are Failing Their cART and Have Dual- or Triple-class Antiretroviral Resistance

Who this might be right for
HIV Infections With Multi Drug Resistant Virus
PENTA Foundation 60
Not applicableStudy completedNCT04208789
What this trial is testing

Artificial Inteligent for Diagnosing Drug-Resistant Tuberculosis

Who this might be right for
MDR TuberculosisResistance to Tuberculostatic Drugs
Hasanuddin University 524
Large-scale testing (Phase 3)Active Not RecruitingNCT02362503
What this trial is testing

Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

Who this might be right for
HIV Infections
ViiV Healthcare 371
Not applicableStudy completedNCT00262717
What this trial is testing

Can Resistance Enhance Selection of Treatment? (CREST)

Who this might be right for
HIV Infection
Kirby Institute 338
Large-scale testing (Phase 3)Study completedNCT02342886
What this trial is testing

Shortening Treatment by Advancing Novel Drugs

Who this might be right for
Tuberculosis, Pulmonary, Drug SensitiveTuberculosis, Pulmonary, Multi Drug-resistant
Global Alliance for TB Drug Development 284
Testing effectiveness (Phase 2)Study completedNCT00000838
What this trial is testing

Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 256
Testing effectiveness (Phase 2)Study completedNCT04179500
What this trial is testing

A Trial to Evaluate the Male Reproductive Safety of Pretomanid in Adult Male Participants With Drug Resistant Pulmonary Tuberculosis

Who this might be right for
Tuberculosis, PulmonaryTuberculosis, Multidrug-ResistantTuberculosis, MDR+2 more
Global Alliance for TB Drug Development 26
Not applicableStudy completedNCT03259269
What this trial is testing

Expand New Drugs for TB [endTB]

Who this might be right for
Tuberculosis, Multidrug-Resistant
Partners in Health 2,804
Large-scale testing (Phase 3)Study completedNCT00023153
What this trial is testing

Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection

Who this might be right for
HIV InfectionsChronic Hepatitis B
National Institute of Allergy and Infectious Diseases (NIAID) 100
Not applicableLooking for participantsNCT06529237
What this trial is testing

Malaria Molecular Surveillance in Mozambique (Phase 2)

Who this might be right for
MalariaFalciparum MalariaMalaria in Pregnancy
Centro de Investigacao em Saude de Manhica 18,750
Not applicableWithdrawnNCT02640495
What this trial is testing

Artemisinin Resistance In Malaria Treated With IV Artesunate

Who this might be right for
Malaria
University of Oxford
Large-scale testing (Phase 3)Ended earlyNCT02806141
What this trial is testing

Aerosolized Plus Intravenous vs. Intravenous Colistin for VAP Due to Pandrugs-resistant A. Baumannii in Neonates

Who this might be right for
Pneumonia, Ventilator-AssociatedColistin Adverse ReactionInfection Due to Multidrug Resistant Acinetobacter+1 more
Hat Yai Medical Education Center 204
Early research (Phase 1)Study completedNCT02312986
What this trial is testing

FMT for Multidrug Resistant Organism Reversal

Who this might be right for
Infection With Multi-drug Resistant Organisms
Washington University School of Medicine 1
Large-scale testing (Phase 3)WithdrawnNCT00011128
What this trial is testing

Salvage Treatment, Resistance Testing, and Withdrawal of Anti-HIV Drugs for HIV Patients Failing Current Anti-HIV Treatment

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID)
Not applicableStudy completedNCT00000859
What this trial is testing

Trial of the Efficacy and Safety of a Strategy of Starting With Nelfinavir Versus Ritonavir Added to Background Antiretroviral (AR) Nucleoside Therapy in HIV-Infected Individuals With CD4+ Cell Counts Less Than or Equal to 200/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 1,300
Not applicableUnknownNCT06156956
What this trial is testing

Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol

Who this might be right for
Drug Resistance, BacterialAntimicrobial Drug Resistance
Human Biome Institute S.A. 200
Large-scale testing (Phase 3)Ended earlyNCT00612898
What this trial is testing

Study of the Efficacy and Safety of Apricitabine, a New NRTI, to Treat Drug-resistant HIV Infection

Who this might be right for
HIV Infections
Avexa 239
Load More Results